#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	490	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c17.ctg.1	817	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(2')-Ic;b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis."
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	316	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	1228	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Erm(37);b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.'
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2194T	SNP	2194	2194	C	64	64	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	G2301A	SNP	2301	2301	G	171	171	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2346T	SNP	2346	2346	C	216	216	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2347C	SNP	2347	2347	A	217	217	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T2358G	SNP	2358	2358	T	228	228	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2361G	SNP	2361	2361	A	231	231	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T2362C	SNP	2362	2362	T	232	232	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2399G	SNP	2399	2399	A	269	269	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2402T	SNP	2402	2402	C	272	272	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	G2408C	SNP	2408	2408	G	278	278	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T2418A	SNP	2418	2418	T	289	289	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	298	298	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	300	300	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2526G	SNP	2526	2526	A	397	397	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	407	407	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	464	464	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2895G	SNP	2895	2895	A	766	766	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T2896C	SNP	2896	2896	T	767	767	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T2906C	SNP	2906	2906	T	777	777	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	780	780	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2915G	SNP	2915	2915	A	786	786	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	G2920C	SNP	2920	2920	G	791	791	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	811	811	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T3002C	SNP	3002	3002	T	873	873	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A3005G	SNP	3005	3005	A	876	876	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A3007T	SNP	3007	3007	A	878	878	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C3028A	SNP	3028	3028	C	899	899	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	909	909	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	T3045C	SNP	3045	3045	T	916	916	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C3062T	SNP	3062	3062	C	933	933	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	938	938	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	0	.	n	.	0	C3071T	SNP	3071	3071	C	942	942	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	945	95.98	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	946	0.0	1	SNP	n	A2268C	0	.	.	2268	2268	A	138	138	A	ND	ND	ND	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159:0:0:A2268C:.:b'Point mutation in the 23S rRNA of Mycobaccterium avium shown to confer resistance to azithromycin, a macrolide type antibiotic.'	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	T1734C	SNP	1734	1734	T	20	20	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	A1744G	SNP	1744	1744	A	30	30	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	T1751C	SNP	1751	1751	T	37	37	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	T1798C	SNP	1798	1798	T	84	84	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	A1820G	SNP	1820	1820	A	106	106	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	A1841C	SNP	1841	1841	A	127	127	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	G1914A	SNP	1914	1914	G	200	200	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	C1923T	SNP	1923	1923	C	209	209	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	C1957T	SNP	1957	1957	C	243	243	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	T1974G	SNP	1974	1974	T	260	260	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	.2074C	INS	2074	2074	C	361	361	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	134	Mycobacterium_intracellulare_23S_1	3103	401	96.53	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	435	0.0	0	.	n	.	0	.2079G	INS	2079	2079	A	367	367	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	531	294	Mycobacterium_tuberculosis_16S_4	1537	1537	99.93	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	1980	0.0	0	.	n	.	0	C517T	SNP	517	517	C	829	829	T	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	531	294	Mycobacterium_tuberculosis_16S_4	1537	1537	99.93	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	1980	0.0	1	SNP	n	A1401G	0	.	.	1401	1401	A	1713	1713	A	ND	ND	ND	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921:0:0:A1401G:.:b"Point mutations in the 3' domain of 16S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin."	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	531	1062	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	99.92	Mycobacterium_tuberculosis_Rv1258c_1.l15.c4.ctg.1	1799	0.0	0	.	p	.	0	E194fs	FSHIFT	580	580	G	949	949	C	ND	ND	ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	38	40	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	53	55	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	476	478	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	656	658	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1130	1132	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1226	1228	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1265	1267	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.1	1824	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1343	1345	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	L399M	NONSYN	1195	1197	CTG	293	295	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	L422H	NONSYN	1264	1266	CTC	362	364	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	T424P	NONSYN	1270	1272	ACT	368	370	CCT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	R426L	NONSYN	1276	1278	CGC	374	376	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	Q428S	NONSYN	1282	1284	CAG	380	382	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	100	92.0	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.2	585	0.0	0	.	p	.	0	T430A	NONSYN	1288	1290	ACC	386	388	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	F24L	NONSYN	70	72	TTC	232	234	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	.	MULTIPLE	1258	1260	ACT	317	319	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	L422P	NONSYN	1264	1266	CTC	323	325	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	.	MULTIPLE	1268	1269	GT	328	329	CG	ND;ND	ND;ND	ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	R425G	NONSYN	1273	1275	CGC	333	335	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	R426S	NONSYN	1276	1278	CGC	336	338	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	0	.	p	.	0	F437V	NONSYN	1309	1311	TTT	369	371	GTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	199	201	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	527	1052	Mycobacterium_tuberculosis_ndh	1392	300	93.18	Mycobacterium_tuberculosis_ndh.l6.c4.ctg.3	441	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	214	216	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	C69T	SNP	69	69	C	213	213	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	.75A	INS	75	75	G	220	220	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	G77A	SNP	77	77	G	222	222	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	T129C	SNP	129	129	T	274	274	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	C174G	SNP	174	174	C	319	319	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	C176A	SNP	176	176	C	321	321	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	T178G	SNP	178	178	T	323	323	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	G183T	SNP	183	183	G	328	328	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	A186T	SNP	186	186	A	331	331	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	C193G	SNP	193	193	C	338	338	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	.196GC	INS	196	196	A	342	342	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	T202A	SNP	202	202	T	349	349	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	T249C	SNP	249	249	T	396	396	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	C254T	SNP	254	254	C	401	401	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	A258C	SNP	258	258	A	405	405	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	348	93.18	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	495	0.0	0	.	n	.	0	A291T	SNP	291	291	A	438	438	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A575T	SNP	575	575	A	29	29	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A581G	SNP	581	581	A	35	35	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G593A	SNP	593	593	G	47	47	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T741G	SNP	741	741	T	195	195	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T863C	SNP	863	863	T	317	317	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A870G	SNP	870	870	A	324	324	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T975C	SNP	975	975	T	429	429	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	C977T	SNP	977	977	C	431	431	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A990G	SNP	990	990	A	444	444	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1086C	SNP	1086	1086	T	540	540	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1098A	SNP	1098	1098	G	552	552	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1099C	SNP	1099	1099	G	553	553	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	C1107T	SNP	1107	1107	C	561	561	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1119A	SNP	1119	1119	G	573	573	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A1211G	SNP	1211	1211	A	665	665	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1217A	SNP	1217	1217	G	671	671	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A1228T	SNP	1228	1228	A	682	682	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1233C	SNP	1233	1233	T	687	687	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A1234G	SNP	1234	1234	A	688	688	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1239T	SNP	1239	1239	G	693	693	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	G1240A	SNP	1240	1240	G	694	694	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	C1250T	SNP	1250	1250	C	704	704	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1252A	SNP	1252	1252	T	706	706	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1258C	SNP	1258	1258	T	712	712	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1274C	SNP	1274	1274	T	728	728	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	A1295G	SNP	1295	1295	A	749	749	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	873	873	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	874	874	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	829	829	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	830	830	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	164	Mycobacteroides_abscessus_16S_4	1504	958	96.45	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	1082	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	912	912	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A555T	SNP	555	555	A	29	29	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A561G	SNP	561	561	A	35	35	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G573A	SNP	573	573	G	47	47	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T721G	SNP	721	721	T	195	195	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T843C	SNP	843	843	T	317	317	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A850G	SNP	850	850	A	324	324	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G947A	SNP	947	947	G	421	421	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A956G	SNP	956	956	A	430	430	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T969C	SNP	969	969	T	443	443	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A970G	SNP	970	970	A	444	444	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C986T	SNP	986	986	C	460	460	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1065T	SNP	1065	1065	C	539	539	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1066C	SNP	1066	1066	T	540	540	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1079C	SNP	1079	1079	G	553	553	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1086G	SNP	1086	1086	C	560	560	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1087T	SNP	1087	1087	C	561	561	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A1098G	SNP	1098	1098	A	572	572	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1099A	SNP	1099	1099	G	573	573	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A1191G	SNP	1191	1191	A	665	665	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1197A	SNP	1197	1197	G	671	671	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A1208T	SNP	1208	1208	A	682	682	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A1214G	SNP	1214	1214	A	688	688	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1220A	SNP	1220	1220	G	694	694	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1230T	SNP	1230	1230	C	704	704	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1232A	SNP	1232	1232	T	706	706	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1238C	SNP	1238	1238	T	712	712	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1254C	SNP	1254	1254	T	728	728	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A1275G	SNP	1275	1275	A	749	749	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	871	871	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	874	874	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	915	96.28	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	1082	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	829	829	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	.47T	INS	47	47	G	336	336	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	C49T	SNP	49	49	C	338	338	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	G57A	SNP	57	57	G	347	347	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	C108T	SNP	108	108	C	398	398	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	T109C	SNP	109	109	T	399	399	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	A153G	SNP	153	153	A	443	443	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	C156A	SNP	156	156	C	446	446	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	T158G	SNP	158	158	T	448	448	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	G165T	SNP	165	165	G	455	455	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	A166T	SNP	166	166	A	456	456	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	C173G	SNP	173	173	C	463	463	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	.176GC	INS	176	176	A	467	467	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	T182A	SNP	182	182	T	474	474	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	A227G	SNP	227	227	A	519	519	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	T229C	SNP	229	229	T	521	521	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	C234T	SNP	234	234	C	526	526	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	A238C	SNP	238	238	A	530	530	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	148	Mycobacteroides_chelonae_16S_4	1441	328	92.77	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	620	0.0	0	.	n	.	0	A271T	SNP	271	271	A	563	563	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	722	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1497	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	1106	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	1881	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	efpA;b'efpA is an MFS transporter found in Mycobacterium tuberculosis.'
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	275	277	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	278	280	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	866	868	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1226	1228	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1313	1315	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1649	1651	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2762	2764	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2148	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3657	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	3002	3004	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	0	.	p	.	0	D354A	NONSYN	1060	1062	GAC	1172	1174	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	827	829	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	830	832	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1001	1003	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1007	1009	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1028	1030	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1028	1030	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1028	1030	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1028	1030	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1043	1045	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1067	1069	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1067	1069	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1094	1096	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1094	1096	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1100	1102	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1109	1111	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1112	1114	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1178	1180	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1181	1183	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1214	1216	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1235	1237	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1244	1246	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1250	1252	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1301	1303	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1307	1309	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1328	1330	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1328	1330	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1328	1330	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1328	1330	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1349	1351	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1448	1450	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1490	1492	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1505	1507	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1517	1519	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1523	1525	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1601	1603	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1601	1603	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1622	1624	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1631	1633	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2345	2347	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	2987	2989	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3110	3112	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	2348	embB_1	3297	3297	99.97	embB_1.l15.c4.ctg.1	3505	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3182	3184	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	859	861	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	871	873	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	880	882	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	928	930	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	973	975	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	979	981	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	982	984	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	982	984	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1006	1008	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1006	1008	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1009	1011	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1009	1011	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1018	1020	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1024	1026	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1027	1029	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1039	1041	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1042	1044	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1045	1047	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1048	1050	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1093	1095	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1096	1098	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1099	1101	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1300	1302	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1312	1314	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1591	1593	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1624	1626	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	R738Q	0	.	.	2212	2214	CGG	2332	2334	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	2550	embC	3285	3285	99.97	embC.l15.c17.ctg.1	3512	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3061	3063	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	954	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1643	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	547	549	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	954	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1643	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1354	1356	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	252	254	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	273	275	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	294	296	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	336	338	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	342	344	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	375	377	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	474	476	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	591	593	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	705	707	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	726	728	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	735	737	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	906	908	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	930	932	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	969	971	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1155	1157	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1191	1193	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1203	1205	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1224	1226	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1284	1286	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1353	1355	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1377	1379	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1222	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1830	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1608	1610	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	229	231	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	289	291	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	289	291	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	298	300	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	298	300	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	298	300	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	316	318	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	316	318	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	337	339	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	442	444	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	619	621	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	619	621	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	628	630	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	628	630	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	900	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1773	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1429	1431	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	0	.	p	.	0	E92D	NONSYN	274	276	GAA	378	380	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	192	194	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	213	215	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	237	239	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	237	239	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	243	245	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	246	248	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	249	251	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	267	269	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	303	305	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	312	314	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	315	317	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	327	329	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	339	341	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	339	341	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	354	356	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	354	356	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	453	455	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	474	476	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	483	485	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	504	506	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	516	518	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	519	521	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	546	548	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	594	596	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	651	653	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	651	653	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	666	668	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	666	668	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	494	gidB	675	675	99.7	gidB.l6.c4.ctg.1	1004	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	702	704	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	170	172	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	392	394	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2111	2113	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	329	331	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	347	349	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	371	373	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	371	373	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	374	376	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	374	376	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	374	376	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	377	379	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	377	379	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	380	382	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1822	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2733	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	413	415	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1539	1541	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	2019	2021	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	2133	2135	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	2133	2135	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	2136	2138	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	2136	2138	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	2139	2141	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1508	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2778	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	2139	2141	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	437	439	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	452	454	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	452	454	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	530	532	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	623	625	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	671	673	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	674	676	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	812	814	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	466	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1387	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	971	973	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1622	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2269	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	236	238	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1622	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2269	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1151	1153	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1622	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2269	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1730	1732	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1622	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2269	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1838	1840	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	1	626	iniB	1440	1201	100.0	iniB.l15.c4.ctg.1	1487	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	425	427	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	1	626	iniB	1440	167	100.0	iniB.l15.c4.ctg.2	414	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	1104	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	1907	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	418	420	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	1104	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	1907	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	913	915	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	479	481	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	644	646	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1088	1090	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1217	1219	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1442	1444	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	784	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1660	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1520	1522	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	S315T	1	S315T	NONSYN	943	945	AGC	1070	1072	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1514	1516	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	224	226	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	398	400	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	455	457	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	458	460	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	500	502	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	503	505	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	506	508	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	551	553	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	566	568	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	917	919	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1061	1063	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1376	1378	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1508	1510	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1595	1597	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1649	1651	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	1946	1948	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1526	katG_1	2223	2223	99.91	katG_1.l15.c17.ctg.1	2407	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2105	2107	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	514	mfpA	552	552	100.0	mfpA.l15.c4.ctg.1	915	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	539	994	mshA_1	1443	1443	99.93	mshA_1.l15.c17.ctg.1	1744	0.0	0	.	p	.	0	A187V	NONSYN	559	561	GCA	704	706	GTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	539	994	mshA_1	1443	1443	99.93	mshA_1.l15.c17.ctg.1	1744	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1208	1210	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	772	murA_4	1257	1257	100.0	murA_4.l15.c4.ctg.1	1530	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	480	482	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	203	205	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	209	211	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	212	214	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	215	217	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	221	223	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	221	223	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	221	223	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	224	226	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	227	229	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	227	229	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	230	232	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	230	232	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	230	232	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	236	238	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	236	238	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	236	238	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	242	244	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	242	244	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	251	253	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	251	253	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	257	259	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	269	271	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	278	280	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	281	283	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	302	304	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	323	325	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	335	337	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	338	340	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	338	340	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	341	343	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	341	343	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	341	343	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	347	349	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	347	349	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	353	355	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	353	355	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	359	361	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	362	364	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	362	364	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	371	373	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	371	373	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	374	376	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	386	388	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	398	400	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	401	403	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	404	406	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	404	406	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	404	406	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	404	406	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	404	406	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	407	409	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	413	415	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	416	418	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	416	418	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	428	430	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	428	430	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	434	436	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	446	448	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	455	457	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	455	457	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	470	472	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	482	484	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	488	490	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	488	490	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	488	490	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	488	490	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	491	493	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	500	502	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	506	508	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	506	508	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	509	511	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	509	511	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	512	514	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	548	550	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	554	556	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	563	565	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	575	577	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	596	598	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	599	601	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	602	604	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	605	607	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	608	610	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	608	610	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	608	610	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	611	613	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	611	613	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	614	616	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	614	616	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	614	616	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	617	619	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	617	619	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	617	619	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	620	622	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	623	625	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	626	628	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	626	628	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	638	640	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	662	664	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	665	667	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	671	673	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	677	679	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	680	682	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	683	685	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	683	685	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	692	694	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	704	706	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	713	715	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	713	715	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	713	715	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	716	718	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	716	718	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	722	724	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	725	727	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	740	742	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	474	pncA	561	561	100.0	pncA.l15.c4.ctg.1	1050	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	746	748	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	670	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1263	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	162	164	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	686	688	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1598	1600	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1763	1765	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1772	1774	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1772	1774	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1772	1774	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1772	1774	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1772	1774	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1781	1783	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1796	1798	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2254	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4095	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1826	1828	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	1174	1176	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	571	573	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	568	570	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	520	522	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	517	519	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	514	516	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	511	513	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	283	1246	rpsA	1446	1446	99.93	rpsA.l15.c4.ctg.1	1839	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	490	492	TAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	418	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	751	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	272	274	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	418	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	751	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	281	283	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	418	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	751	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	416	418	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	418	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	751	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	416	418	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	C949.	DEL	949	949	C	10	10	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	.953T	INS	953	953	C	15	15	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	.959A	INS	959	959	T	22	22	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	G963.	DEL	963	963	G	25	25	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	T1076A	SNP	1076	1076	T	138	138	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	T1207C	SNP	1207	1207	T	269	269	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	G1214A	SNP	1214	1214	G	276	276	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	T1224.	DEL	1224	1224	T	285	285	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	C1227A	SNP	1227	1227	C	288	288	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	G1380A	SNP	1380	1380	G	441	441	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	T1394C	SNP	1394	1394	T	455	455	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	T1396.	DEL	1396	1396	T	456	456	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	0	.	n	.	0	C1406T	SNP	1406	1406	C	466	466	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	516	96.91	rrsB_9.l15.c4.ctg.1	588	0.0	1	SNP	n	C1439U	0	.	.	1439	1439	C	499	499	C	ND	ND	ND	rrsB.3003540.X52922.1.0_1454.4148:0:0:C1439U:.:b'Point mutations in the highly conserved helix 44 of the 16S rrsB rRNA gene of Mycolicibacterium smegmatis can confer resistance to hygromycin B. Resistance against hygromycin B is the result of conformational alterations that distorts a strong hydrogen bond leading to a change in the local geometry of the hygromycin B binding site.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	132	rrsB_9	1454	315	98.73	rrsB_9.l15.c4.ctg.3	315	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A590T	SNP	590	590	A	29	29	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	A596G	SNP	596	596	A	35	35	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G608A	SNP	608	608	G	47	47	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C990.	DEL	990	990	C	428	428	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G993T	SNP	993	993	G	431	431	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	.994T	INS	994	994	C	433	433	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1002G	SNP	1002	1002	T	442	442	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1004.	DEL	1004	1004	G	443	443	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1117A	SNP	1117	1117	T	556	556	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1248C	SNP	1248	1248	T	687	687	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1254T	SNP	1254	1254	G	693	693	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1255A	SNP	1255	1255	G	694	694	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1265.	DEL	1265	1265	T	703	703	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1268A	SNP	1268	1268	C	706	706	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	G1421A	SNP	1421	1421	G	859	859	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	T1437.	DEL	1437	1437	T	874	874	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	0	.	n	.	0	C1447T	SNP	1447	1447	C	884	884	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	1	SNP	n	G1475A	0	.	.	1475	1475	G	912	912	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475A:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	967	98.04	rrsB_13.l6.c4.ctg.1	1082	0.0	1	SNP	n	G1475U	0	.	.	1475	1475	G	912	912	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475U:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	C81T	SNP	81	81	C	338	338	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	T82C	SNP	82	82	T	339	339	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	G90A	SNP	90	90	G	347	347	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	T142C	SNP	142	142	T	399	399	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	A175G	SNP	175	175	A	432	432	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	A180G	SNP	180	180	A	437	437	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	C181A	SNP	181	181	C	438	438	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	G185A	SNP	185	185	G	441	441	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	T187G	SNP	187	187	T	443	443	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	C191T	SNP	191	191	C	447	447	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	C198T	SNP	198	198	C	453	453	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	G201T	SNP	201	201	G	456	456	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	A204G	SNP	204	204	A	459	459	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	G206T	SNP	206	206	G	461	461	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	.211GC	INS	211	211	A	467	467	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	T217A	SNP	217	217	T	474	474	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	176	rrsB_13	1528	262	90.91	rrsB_13.l6.c4.ctg.2	520	0.0	0	.	n	.	0	G231A	SNP	231	231	G	488	488	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	140	142	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	182	184	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	299	301	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	305	307	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	323	325	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	347	349	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	377	379	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	389	391	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	452	454	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	530	532	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	557	559	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	680	682	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	695	697	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	746	748	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	622	thyA	792	792	100.0	thyA.l15.c17.ctg.1	948	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	779	781	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	139	141	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	298	300	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	304	306	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	370	372	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	451	453	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	481	483	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	547	549	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	646	648	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	652	654	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	805	807	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	652	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1229	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	811	813	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
